Standout Papers

Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines 1997 2026 2006 2016 1.1k
  1. Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines (1997)
    Bonnee Rubinfeld, Paul F. Robbins et al. Science
  2. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells (2013)
    Paul F. Robbins, Yong‐Chen Lu et al. Nature Medicine
  3. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response (2014)
    Paul F. Robbins, Sadik H. Kassim et al. Clinical Cancer Research

Immediate Impact

12 by Nobel laureates 51 from Science/Nature 156 standout
Sub-graph 1 of 13

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
The Emerging Landscape of Immune Cell Therapies
2020 Standout
24 intermediate papers

Works of Mona El‐Gamil being referenced

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
2014 Standout
Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide Bond
2007
and 20 more

Author Peers

Author Last Decade Papers Cites
Mona El‐Gamil 4367 3967 2733 41 6.5k
John R. Yannelli 5444 3597 2141 74 7.2k
Hyam I. Levitsky 6671 3686 1894 65 8.2k
Todd D. Prickett 3133 3895 2300 52 5.7k
Maria R. Parkhurst 7071 5872 3099 63 9.0k
Jared J. Gartner 4244 5059 2265 59 6.7k
Thomas Wölfel 5110 2821 2737 70 6.4k
Paul J. Spiess 6731 4693 2109 40 8.3k
Christophe Lurquin 7289 3240 4680 44 8.8k
Yong F. Li 4236 4636 1399 43 5.8k
Robert Somerville 2768 3536 1792 77 5.8k

All Works

Loading papers...

Rankless by CCL
2026